Format

Send to:

Choose Destination
See comment in PubMed Commons below
Pharmacotherapy. 1991;11(4):340-3.

Buspirone in the treatment of posttraumatic stress disorder.

Author information

  • 1Department of Clinical Pharmacy, University of Tennessee, Memphis.

Abstract

Three patients with a DSM-III-R diagnosis of posttraumatic stress disorder were successfully treated with buspirone in final maximum dosages ranging from 35-60 mg daily. The onset of clinical efficacy ranged from 5-29 days. Symptoms that improved included anxiety, insomnia, flashbacks, and depressed mood. Patients experienced no side effects. Serotonin partial agonist effects are a possible mechanism underlying buspirone's efficacy.

PMID:
1923917
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for John Wiley & Sons, Inc.
    Loading ...
    Write to the Help Desk